Endocare Inc. Rejects HealthTronics Buyout Offer on Price

Calls $26.9 million offer 'inadequate'

Medical device maker Endocare Inc. is rejecting a buyout bid from urology product maker HealthTronics Inc. because the $26.9 million offer is inadequate.

Endocare said its board unanimously rejected the all-cash bid, worth $2.28 per share. Austin, TX-based HealthTronics offered a 20% premium to Endo’s most recent closing price in an attempt to widen its product range.

Calls seeking comment from HealthTronics were not immediately returned.

SOURCE: Associated Press



Add us as a preferred source on Google

Get the latest Medical Product Outsourcing news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters